SPY772.04+0.09%QQQ745.40+0.12%BTC/USD83,096.41−1.60%DIA517.72+0.04%GLD393.05−0.09%TLT79.38+0.08%
Benzinga

Sagimet Biosciences Inc (SGMT) Stock Price, Quote, News & History

SGMTNASDAQ
Trade with Public
Trade with Public
$9.24
0.131.43%
At close: Sep 25, 5:00 PM EST
$9.20
-0.04-0.43%
After Hours: Sep 25, 7:55 PM EST
OverviewNewsEarnings ForecastEventsPrice TargetsFinancialsSentimentOwnershipCompareOptionsStock Report

Sagimet Biosciences (SGMT) Stock Price, Quote, News & History | Benzinga

Key Statistics

Open
$9.11
Close
$9.24
Volume / Avg.
1.25M / 1.27M
Day Range
$8.89 - $9.27
52 Wk Range
4.50 - 11.45
Market Cap
$571.86M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
40
Short Interest
16.81%
Days to Cover
10.56

Recent Sagimet Biosciences Inc. News

This Illumina Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday

Analysts upgraded Sagimet, Figure, Illumina, Martin Marietta and Waters, raising price targets and improving ratings.
Avi Kapoor

Alpha Buying: 4 Biotech Stocks a Healthcare Specialist Is Buying

Biotechnology investing is a strange corner of the market. A company can own a drug that may eventually produce billions of dollars in sales and still find itself scrambling to raise enough cash to survive another
Tim Melvin

Legend Biotech, Sleep Number And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

US stock futures up, Nasdaq futures 1% higher. Legend Biotech (LEGN) priced 7.7 million ADSs at $29.35 each, shares down 9% in pre-market trading.
Avi Kapoor

Why Is Sagimet Biosciences Stock Trading Higher On Monday?

Sagimet shares surge as Phase 3 acne trial plans and $175M offering fund pipeline through 2028, with technicals showing strong momentum.
Vandana Singh

This Visa Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday

Avi Kapoor

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-41.72M
Investing Cash Flow (TTM)
629.00K
Financing Cash Flow (TTM)
164.66M
Free Cash Flow (TTM)
-41.72M
Capital Expenditure (TTM)
-
Net Change in Cash (TTM)
123.57M

Analyst Trends and Forecast

1
Apr
1
May
2
Aug
2
1
Sep
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.1
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$335.85M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
-
PB Ratio (TTM)
2.24
Earnings Yield % (TTM)
-13.64%
Earnings Yield % (FWD)
-10.66%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$4.12

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$165.90M
Debt to Equity
0.01
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
$9.11
Close
$9.24
Volume / Avg.
1.25M / 1.27M
Day Range
$8.89 - $9.27
52 Wk Range
4.50 - 11.45
Market Cap
$571.86M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
40
Short Interest
16.81%
Days to Cover
10.56

About

Sector
Health Care
Industry
Biotechnology
Sagimet Biosciences Inc a clinical-stage biopharmaceutical company developing novel therapeutics called fatty acid synthase (FASN) inhibitors that target dysfunctional metabolic and fibrotic pathways in diseases resulting from the overproduction of t...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

FAQ

Q

How do I buy Sagimet Biosciences (SGMT) stock?

A

You can purchase shares of Sagimet Biosciences (NASDAQ:SGMT) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Sagimet Biosciences (SGMT) competitors?

Q

What is the forecast, or price target, for Sagimet Biosciences (SGMT) stock?

A

Sagimet Biosciences has a consensus price target of $24.79.

Q

What is the current price for Sagimet Biosciences (SGMT)?

A

The stock price for Sagimet Biosciences (NASDAQ: SGMT) is $9.2 last updated September 25, 2026 at 7:55 PM EDT.

Q

Does Sagimet Biosciences (SGMT) pay a dividend?

A

There are no upcoming dividends for Sagimet Biosciences.

Q

When is Sagimet Biosciences (NASDAQ:SGMT) reporting earnings?

A

Sagimet Biosciences does not have any upcoming earnings scheduled.

Q

Is Sagimet Biosciences (SGMT) going to split?

A

There is no upcoming split for Sagimet Biosciences.

Q

What sector and industry does Sagimet Biosciences (SGMT) operate in?

A

Sagimet Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Data & APIs: Benzinga APIs · Stock News API · Analyst Ratings API · Company Logo API

Market data provided by Benzinga APIs

Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved